Cargando…
Review of Current Strategies for Delivering Alzheimer’s Disease Drugs across the Blood-Brain Barrier
Effective therapy for Alzheimer’s disease is a major challenge in the pharmaceutical sciences. There are six FDA approved drugs (e.g., donepezil, memantine) that show some effectiveness; however, they only relieve symptoms. Two factors hamper research. First, the cause of Alzheimer’s disease is not...
Autores principales: | Wong, Ka Hong, Riaz, Muhammad Kashif, Xie, Yuning, Zhang, Xue, Liu, Qiang, Chen, Huoji, Bian, Zhaoxiang, Chen, Xiaoyu, Lu, Aiping, Yang, Zhijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358942/ https://www.ncbi.nlm.nih.gov/pubmed/30658419 http://dx.doi.org/10.3390/ijms20020381 |
Ejemplares similares
-
Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer’s Disease
por: Wong, Ka Hong, et al.
Publicado: (2020) -
Pulmonary delivery of transferrin receptors targeting peptide surface-functionalized liposomes augments the chemotherapeutic effect of quercetin in lung cancer therapy
por: Riaz, Muhammad Kashif, et al.
Publicado: (2019) -
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
por: Riaz, Muhammad Kashif, et al.
Publicado: (2018) -
Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide
por: Lin, Congcong, et al.
Publicado: (2018) -
Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma
por: Zhang, Xue, et al.
Publicado: (2017)